Peptide
AssigneesQueen Mary University of London, Barts Health Nhs Trust
InventorsFederica Maria MARELLI-BERG, Maria Paula LONGHI, Saidi MOHIDDIN
Life of this patent
Estimating the term…
Abstract
The present invention relates to peptides derived from COVID-19 virus envelope protein and spike protein. The invention further relates to polynucleotides and vectors encoding said peptides, and antibodies and chimeric antigen receptors that bind to said peptides. The invention also relates to methods of diagnosis and prediction of conditions in a subject which leverage recognition of said peptides, such as by antigen-specific T cells.
Claims34
A peptide selected from the group consisting of:
- (SEQ ID NO 1)
- MYSFVSEETGTLIVNSV,
- (SEQ ID NO 2)
- LLHAPATVCGPKKST,
- (SEQ ID NO 3)
- NKKFLPFQQFGRDIA,
- (SEQ ID NO 4)
- PHGVVFLHVTYVPAQ,
- and variants thereof having at least 80% identity to any one of SEQ ID NOs 1, 2, 3 or 4.
4-6. (canceled)
(canceled)
(canceled)
15-17. (canceled)
(canceled)
21-22. (canceled)
25-29. (canceled)
31-32. (canceled)
34-36. (canceled)
(canceled)
40-43. (canceled)
45-46. (canceled)
48-51. (canceled)
53-56. (canceled)
Dependencies are inferred from the claim text.